My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 567

    1.

    Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.

    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA.

    Diabetes. 2001 Mar;50(3):565-72.PMID: 11246876 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.

    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA.

    Diabetologia. 2001 Jun;44(6):729-37.PMID: 11440366 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.

    Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA.

    Diabetes. 2000 Apr;49(4):611-7.PMID: 10871199 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.

    Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA.

    Diabetologia. 2002 Oct;45(10):1410-5. Epub 2002 Sep 5. Erratum in: Diabetologia. 2003 Nov;46(11):1589. PMID: 12378382 [PubMed - indexed for MEDLINE]Related articles

    5.

    Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.

    Ryan AS, Egan JM, Habener JF, Elahi D.

    J Clin Endocrinol Metab. 1998 Jul;83(7):2399-404.PMID: 9661618 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.

    Sandhu H, Wiesenthal SR, MacDonald PE, McCall RH, Tchipashvili V, Rashid S, Satkunarajah M, Irwin DM, Shi ZQ, Brubaker PL, Wheeler MB, Vranic M, Efendic S, Giacca A.

    Diabetes. 1999 May;48(5):1045-53.PMID: 10331409 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.

    Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Elahi D.

    J Gerontol A Biol Sci Med Sci. 2001 Nov;56(11):M681-5.PMID: 11682575 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.

    Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA.

    Diabetes. 2000 Feb;49(2):272-83.PMID: 10868944 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.

    Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA.

    Diabetes. 2002 Feb;51(2):301-10.PMID: 11812736 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    GLP-1 does not not acutely affect insulin sensitivity in healthy man.

    Orskov L, Holst JJ, Møller J, Orskov C, Møller N, Alberti KG, Schmitz O.

    Diabetologia. 1996 Oct;39(10):1227-32.PMID: 8897012 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

    Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA.

    Diabetes Care. 1996 Jun;19(6):580-6.PMID: 8725855 [PubMed - indexed for MEDLINE]Related articles

    12.

    Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

    Egan JM, Meneilly GS, Habener JF, Elahi D.

    J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73.PMID: 12161508 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

    Toft-Nielsen MB, Madsbad S, Holst JJ.

    Diabetes Care. 1999 Jul;22(7):1137-43.PMID: 10388979 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.

    Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Ehlers MR, Egan JM, Elahi D.

    Diabetes Care. 2003 Mar;26(3):837-42.PMID: 12610046 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.

    Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA.

    Diabetes. 2001 Jun;50(6):1351-62.PMID: 11375336 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.

    Byrne MM, Gliem K, Wank U, Arnold R, Katschinski M, Polonsky KS, Göke B.

    Diabetes. 1998 Aug;47(8):1259-65.PMID: 9703326 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.

    Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA.

    Diabetes. 1998 Nov;47(11):1735-47.PMID: 9792543 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.

    Wise S, Nielsen M, Rizza R.

    J Clin Endocrinol Metab. 1997 Jun;82(6):1828-33.PMID: 9177391 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.

    Basu R, Basu A, Nielsen M, Shah P, Rizza RA.

    J Clin Endocrinol Metab. 1999 Jul;84(7):2314-9.PMID: 10404795 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.

    Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC.

    Diabetes. 1996 Nov;45(11):1524-30.PMID: 8866556 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity